Clinical trial
A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy…
NCT00158093 · Mylan Bertek Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00158093 |
|---|---|
| Title | A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo |
| Official title | A Randomized, Parallel Group Safety Evaluation of Electrocardiographic Intervals and Blood Pressure in Normal Healthy Volunteers After Nebivolol, Atenolol, Moxifloxacin, or Placebo Administration After Single and Repeated Doses |
| Lead sponsor | Mylan Bertek Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Nebivolol, Atenolol, Moxifloxacin |
| Enrollment | 260 |
| Start date | Jun 1, 2003 |
| Completion | Jul 1, 2003 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 12, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: